Back to results
US 2021/0260068 A1Published application
Dpp iv inhibitor formulations
AssigneeBoehringer Ingelheim International GmbH
InventorsAnja KOHLRAUSCH, Patrick ROMER, Gerd SEIFFERT
Life of this patent
Estimating the term…
Abstract
The present invention relates to pharmaceutical compositions of DPP IV inhibitors with an amino group, their preparation and their use to treat diabetes mellitus.
Claims26
A pharmaceutical composition comprising as an active ingredient a DPP IV inhibitor compound of formula
- or a salt thereof, a first diluent, a second diluent, a binder, a disintegrant and a lubricant, wherein the first and second diluents are independently erythritol, low substituted hydroxypropyl cellulose, mannitol, pregelatinized starch, or xylitol.
Dependencies are inferred from the claim text.